4.6 Article

Desmoplastic infantile astrocytoma with atypical phenotype, PTEN homozygous deletion and BRAF V600E mutation

Journal

ACTA NEUROPATHOLOGICA COMMUNICATIONS
Volume 10, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s40478-022-01392-x

Keywords

Desmoplastic infantile astrocytoma; PTEN; BRAF V600E; Atypical

Categories

Funding

  1. Generalitat Valenciana-Spain [GV/2020/048, GRISOLIAP/2021/119, IDIFEDER/2021/072, APOST/2020/196]
  2. Ministerio de Ciencia e Innovacion-Spain [PI14/01669, PID2019-108973RB-C22, PCIN2017-117]
  3. Programa VLC-Bioclinic [AP-2021-001]
  4. Joint Programming Initiative HDH [GUTMOM INTIMIC-085]

Ask authors/readers for more resources

This study reports a case of DIA with genetic features including a BRAF V600E mutation and a homozygous deletion in PTEN, which may be associated with its malignant behavior despite being typically benign.
Desmoplastic infantile astrocytoma (DIA) is rare, cystic and solid tumor of infants usually found in superficial cerebral hemispheres. Although DIA is usually benign, uncommon cases bearing malignant histological and aggressive clinical features have been described in the literature. We report a newborn patient who was diagnosed with a DIA and died postresection. Pathologic examination revealed that the main part of the tumor had benign features, but the internal region showed areas with a more aggressive appearance, with higher-proliferative cells, anaplastic GFAP positive cells with cellular polymorphism, necrosis foci, vascular hyperplasia with endothelial proliferation and microtrombosis. Genetic study, performed in both regions of the tumor, showed a BRAF V600E mutation and a homozygous deletion in PTEN, without changes in other relevant genes like EGFR, CDKN2A, TP53, NFKBIA, CDK4, MDM2 and PDGFRA. Although PTEN homozygous deletions are described in gliomas, the present case constitutes the first report of a PTEN mutation in a DIA, and this genetic feature may be related to the malignant behavior of a usually benign tumor. These genetic findings may point at the need of further and deeper genetic characterization of DIAs, in order to better understand the biology of this tumor and to obtain new prognostic approaches, a better clinical management and targeted therapies, especially in malignant cases of DIA.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available